
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
(Image credit: Catherine Falls Commercial)
Continue reading
Read the full report at NPR News
NPR News supplies a brief version of this story through its feed. Continue to the original publication for the complete report.
Read the original at NPR News
